DBT

Dược phẩm Bến Tre ·HOSE ·2026Q1

▲▲ Improving positively

Operating efficiency is improving Net margin 3.22%, +2.21pp YoY
Price
11,500
Latest close
03 Jun 2026
P/E 8.51x
P/B 0.83x
EPS 1,352
BVPS 13,844
ROE 9.8%
ROA 3.1%
Profit Margin 3.3%
Asset Turnover 0.94x
Equity Mult. 3.21x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DBT has not accelerated revenue sharply, but profitability is improving visibly — earnings have been recovering gradually over multiple periods. However, a significant portion of profit is supported by non-core sources, making the picture not entirely clear.

TTM REVENUE
VND 889bn
+5.3%YoY
NET MARGIN
3.22%
+2.2ppYoY
TTM NET PROFIT
VND 29bn
+233.9%YoY
Non-core income / PBT
37.5%
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 190.0 279.0 177.0 243.2 161.2 258.4 200.6 224.1 185.4 246.1 189.2 202.7
Growth -32% +58% -27% +51% -38% +29% -11% +21% -25% +30% -7%
Net Income 15.3 3.2 0.6 9.6 2.0 4.6 0.6 1.4 6.1 7.2 0.6 -1.5
Net Margin 8.06% 1.14% 0.34% 3.93% 1.27% 1.77% 0.28% 0.62% 3.29% 2.91% 0.33% -0.76%

Drivers of DBT's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by higher financial income. Supporting and offsetting drivers:

Financial income ↑ 19.0bn
Other profit ↑ 14.4bn
Selling expenses ↓ 7.4bn
Gross profit ↓ 6.7bn
Administrative expenses ↑ 5.0bn
Tax ↑ 3.2bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by higher financial income. Supporting and offsetting drivers:

Financial income ↑ 17.3bn
Gross profit ↑ 1.8bn
Tax ↑ 2.3bn
Administrative expenses ↑ 1.4bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 3.1% = 1.0% × 0.91 × 3.41
2026Q1 9.7% = 3.2% × 0.94 × 3.21

ROE rose from 3.1% to 9.7% — mainly driven by asset turnover, despite leverage moving in the opposite direction.

Net margin: 3.2% +2.2pp Asset turnover: 0.94x +0.03x Leverage: 3.21x -0.19x

Is the profit sustainable?

Margins improved (+2.2pp), but earnings still rely significantly on non-core sources — warrants closer scrutiny.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to 3.22%, rising 2.2pp. Core operating signals are improving as SG&A / Revenue fell 2.1pp are enough to offset pressure from Gross margin fell 2.8pp (with additional support from Net financial result / Revenue rose 2.0pp and Other profit / Revenue rose 1.6pp).

Most of the margin increase comes from non-core items — core operations have not kept pace, this is a margin expansion to watch carefully.

Profitability trend

Net Margin 3.22% +2.2pp
Gross Margin 38.31% −2.8pp
SG&A / Revenue 33.22% −2.1pp
Non-core / Revenue -0.51% +3.6pp

TTM YoY · 2025Q1 -> 2026Q1

Watchpoints

Financial result is supporting margin

Financial result accounts for 37.5% of PBT and lifted net margin by 3.6pp — separate the operating contribution from this source.

Is capital being used efficiently?

Return on capital rose, but cash cycle lengthened by 11.1 days — working capital needs watching.

Is capital being deployed efficiently?

ROIC edged up to 2.11%, rising 1.1pp. That translates to 2.11 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 1.1pp, with capital turnover broadly stable; with invested capital holding roughly steady.

NOPAT margin led the improvement, but the ROIC level has not yet cleared typical cost of capital — margin needs to hold in coming periods rather than being a one-period rebound.

Watchpoints

ROIC remains low

ROIC is currently 2.11% — below the typical cost-of-capital threshold; worth tracking whether upcoming periods can rise above this level.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 2.11% +1.1pp
NOPAT Margin 2.01% +1.1pp
Capital Turnover 1.05x +0.02x
Average Invested Capital 849.0bn +30.6bn

Balance Sheet

ROIC is improving — the asset structure below shows how capital is being allocated. Leverage is elevated, requiring monitoring — liabilities at 2.40x equity, net debt at 1.76x equity.

Inventory ended the period at 424.9bn, roughly 42.9% of total assets.

Over the last 12 months, working capital absorbed 2.2bn of cash, mainly because of higher receivables and lower payables. Part of that drag was offset by lower inventories.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables increased → lower CFO: −11.4bn
Inventories decreased → higher CFO: +32.1bn
Payables decreased → lower CFO: −22.9bn

Working Capital Efficiency

The inventory build-up noted above is reflected in a longer cash cycle. Cash conversion cycle lengthened by 11.1 days versus the same period last year. The main moves came from DIO fell 5.7 days, DSO rose 2.0 days, and DPO fell 14.8 days.

Working capital cycle lengthened mainly due to shorter payment timing — may reflect pressure from suppliers.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 319.7 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +2.0 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 77.9 days +2.0 days
Inventory 276.6 days −5.7 days
Payables 34.9 days −14.8 days
Cash Conversion Cycle 319.7 days +11.1 days

Is financial risk significant?

High leverage combined with negative operating cash flow — this area needs close monitoring.

Leverage & Liquidity

Leverage warrants monitoring, with net debt / equity at 1.76x and interest coverage only at 0.58x.

At present, short-term debt accounts for 97.8% of total debt, cash equals 1.4% of debt, and total debt stands at 543.4bn.

Watchpoints

Net leverage is elevated

Net debt / equity stands at 1.76x, increasing balance-sheet pressure.

Interest coverage is thin

Interest coverage is 0.58x, leaving limited room to absorb financing costs.

Leverage and liquidity trend

Net Debt / Equity 1.76x −0.24x
Interest Coverage 0.58x +0.25x
Cash / Debt 1.4% −1.7pp
Short-term Debt / Total Debt 97.8% +2.2pp
CFO / NI 2.19x +8.76x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

High leverage combined with cash flow below reveals the actual liquidity pressure. Operating cash flow reached -10.9bn in 2025, against investing cash flow of 20.2bn.

Post-investment cash flow was positive +9.4bn. Financing cash flow was positive +3.6bn.

CFO / net income was 2.19x.

After spending +2.6bn on fixed-asset investment, the business generated trailing free cash flow of +61.0bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 63.6bn +128.4bn
Cash Capex 2.6bn −26.7bn
FCF TTM +61.0bn +155.1bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 2.2 pp. The next item to monitor is the earnings mix, when non-core contribution is -48.7%. The main risk still sits in capital efficiency remains weak, with ROIC at 2.1%.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 3.22% after expanding 2.2pp versus the same period last year.

Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 2.19x. Even so, net financial result still accounts for -48.7% of PBT, so the earnings mix still needs monitoring.

Key risk: Capital efficiency remains weak.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
860.3 868.4 811.6 754.6 611.2
Cost of Goods Sold
521.9 522.3 502.0 503.4 0.0
Gross Profit
338.4 346.1 309.6 251.2 183.5
Financial Expenses
43.0 40.7 49.7 27.6 -24.7
Selling Expenses
229.9 236.8 192.2 162.0 -137.1
General and Administrative Expenses
63.5 60.1 50.3 53.0 -36.6
Operating Profit
8.9 16.9 22.9 19.2 21.4
Profit Before Tax
24.0 20.4 23.1 50.9 21.8
Net Income
14.4 12.3 17.5 40.5 17.3
Profit Attributable to Parent
14.2 14.6 16.2 38.0 18.1
Earnings per Share
614.00 772.00 893.00 2,261.00 1,273.25

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.